Literature DB >> 24715128

The newer direct oral anticoagulants: a practical guide.

Jecko Thachil1.   

Abstract

Anticoagulation therapy is one of the most important advances in modern medicine, saving thousands of lives from the complications of atrial fibrillation and mechanical heart valves and preventing recurrent venous thromboembolism. Warfarin and heparins have been the predominant anticoagulants used until the past decade. However, the arrival of newer target-specific anticoagulants has brought us easier and equally effective agents, although no specific antidotes are yet available. Being relatively newer drugs, physicians need to be familiar with the various practical issues that may be encountered with the prescription of these drugs, which are summarised in this review.

Entities:  

Keywords:  Anticoagulants; atrial fibrillation; bleeding; coagulation; thrombosis; warfarin

Mesh:

Substances:

Year:  2014        PMID: 24715128      PMCID: PMC4953288          DOI: 10.7861/clinmedicine.14-2-165

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  7 in total

1.  Drug therapy in anticoagulation: which drug for which patient?

Authors:  Carolyn M Millar; Mike A Laffan
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

Review 2.  Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.

Authors:  Allison E Burnett; Charles E Mahan; Sara R Vazquez; Lynn B Oertel; David A Garcia; Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

3.  Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA.

Authors:  Marwan Sheikh-Taha; Hani Dimassi
Journal:  BMC Cardiovasc Disord       Date:  2017-07-17       Impact factor: 2.298

4.  Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.

Authors:  Yuanyuan Wang; Muh Akbar Bahar; Anouk M E Jansen; Janwillem W H Kocks; Jan-Willem C Alffenaar; Eelko Hak; Bob Wilffert; Sander D Borgsteede
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

5.  Influence of ABCB1 Gene Polymorphism on Rivaroxaban Blood Concentration and Hemorrhagic Events in Patients With Atrial Fibrillation.

Authors:  Yan Wang; Min Chen; Hui Chen; Fang Wang
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

6.  Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis.

Authors:  Cedric Hermans; Catherine Lambert
Journal:  J Thromb Haemost       Date:  2020-05-11       Impact factor: 5.824

7.  Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?

Authors:  Raffaele Palmirotta
Journal:  J Pers Med       Date:  2021-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.